上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1157Please respect copyright.PENANATitII8XOMu
1157Please respect copyright.PENANAb090KBVcPL
上集:https://www.penana.com/article/4711251157Please respect copyright.PENANAMppUNsxt6J
1157Please respect copyright.PENANAVyOARrYVkx1157Please respect copyright.PENANAZGix1Z3l7q
1157Please respect copyright.PENANAbxBGEwht1i
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1157Please respect copyright.PENANAnmBZg58UCb
1157Please respect copyright.PENANARe7WMysHMe
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1157Please respect copyright.PENANAZn9eLgHMad
1157Please respect copyright.PENANATL5nIsVT8M
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1157Please respect copyright.PENANApYUVRw3m9S
1157Please respect copyright.PENANA7s8q6jHols1157Please respect copyright.PENANAjsD56DXQHD
1157Please respect copyright.PENANAnWNJJYMksg
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1157Please respect copyright.PENANAHnTCy0EfkE
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1157Please respect copyright.PENANAMwpIyenUo6
1157Please respect copyright.PENANAeCleqVqPem
忘記甚麼是Neoantigen的話,可重溫上一集。1157Please respect copyright.PENANApm74jrAcfR
1157Please respect copyright.PENANARUSGX5ClNQ
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1157Please respect copyright.PENANATGpIpv3yJI
1157Please respect copyright.PENANAS8T3qWgPzw
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1157Please respect copyright.PENANAkz6pUAeDKB
1157Please respect copyright.PENANAPyP1Q91kcT1157Please respect copyright.PENANAeZkniMdqOq
1157Please respect copyright.PENANA04ByvLDpkS
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1157Please respect copyright.PENANAkoFBj4JoEi
1157Please respect copyright.PENANAKNzZ7vH6pf
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1157Please respect copyright.PENANAwzFghjQvnX
1157Please respect copyright.PENANAo0dddVyhBA
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1157Please respect copyright.PENANAubDoXsxIEk1157Please respect copyright.PENANA1AoqPQ0sgi
1157Please respect copyright.PENANAwAbQyVFAEg
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1157Please respect copyright.PENANAzefyBoqh3B
1157Please respect copyright.PENANALO6tatcrxs
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1157Please respect copyright.PENANAOZL1VWMiAm1157Please respect copyright.PENANAi4530x9hVC
1157Please respect copyright.PENANADKBfi2NwlD
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1157Please respect copyright.PENANATIryyn9kRK
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1157Please respect copyright.PENANAMhVbpimHRw
1157Please respect copyright.PENANABlIGCyelec
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1157Please respect copyright.PENANA9yTVnpmak0
1157Please respect copyright.PENANAOPpYvvy5XB
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1157Please respect copyright.PENANAR9FxgGXLOT
1157Please respect copyright.PENANAgG6crVy2nF
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1157Please respect copyright.PENANAEYHHB39wNS
1157Please respect copyright.PENANACzU8Dzggu7
1157Please respect copyright.PENANA4HB0ZJl2qY
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1157Please respect copyright.PENANAh4ocgInVdN
1157Please respect copyright.PENANAIjiTwkRQAO
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1157Please respect copyright.PENANAkGG1hayWW6
1157Please respect copyright.PENANA9iejMg4Qn8
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1157Please respect copyright.PENANATR3E3Wpqow
1157Please respect copyright.PENANASubUY7Hgue
Link:1157Please respect copyright.PENANAoBwKlLI0DV
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1157Please respect copyright.PENANAbGK6Qr7eBx
1157Please respect copyright.PENANAq3Y6T5asSM
1157Please respect copyright.PENANAgsywJmUwqu
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1157Please respect copyright.PENANA6yiQ2hoheb
arrow_back
科普專欄–薯不揀單
more_vert
-
info_outline Info
-
toc Table of Contents
-
share Share
-
format_color_text Display Settings
-
exposure_plus_1 Recommend
-
Sponsor
-
report_problem Report
-
account_circle Login
Search stories, writers or societies
Continue ReadingClear All
What Others Are ReadingRefresh
X
Never miss what's happening on Penana!
科普專欄–薯不揀單
Author:
薯仔聞茱莉
![薯仔聞茱莉](https://static2.penana.com/fit-in/24x24/images/users/large/10/56/10560680635a34d605a71d62.38826921-27349.jpeg)
ISSUE #31
深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)
LIKES 2
READS 1153
BOOKMARKS 148
campaign
Request update 0
Sponsor
![](https://static2.penana.com/img/social/facebook.png)
Click to load the next chapter
X
After each update request, the author will receive a notification!
smartphone100 → Request update
X
Sponsor again
Click to login
Login first to show your name as a sponsor.
Thank you for supporting the story! :)
Please Login first.
×
Write down what you like about the story
×
Reading Theme:
Font Size:
Line Spacing:
Paragraph Spacing:
Load the next issue automatically
Reset to default
×
People Who Like This